Vasopressin: mechanisms of action on the vasculature in health and in septic shock.
about
Vasopressin and terlipressin in adult vasodilatory shock: a systematic review and meta-analysis of nine randomized controlled trialsModulation of splanchnic circulation: Role in perioperative management of liver transplant patientsNon-Adrenergic Vasopressors in Patients with or at Risk for Vasodilatory Shock. A Systematic Review and Meta-Analysis of Randomized TrialscAMP/PKA-dependent increases in Ca Sparks, oscillations and SR Ca stores in retinal arteriolar myocytes after exposure to vasopressin.Role of vasopressin in current anesthetic practice.Copeptin, IGFBP-1, and cardiovascular prognosis in patients with type 2 diabetes and acute myocardial infarction: a report from the DIGAMI 2 trial.The effect of vasopressin on choroidal blood flow, intraocular pressure, and orbital venous pressure in rabbits.The selective vasopressin type 1a receptor agonist selepressin (FE 202158) blocks vascular leak in ovine severe sepsis*Role of selective V2-receptor-antagonism in septic shock: a randomized, controlled, experimental studyChanges in Plasma Copeptin Levels during Hemodialysis: Are the Physiological Stimuli Active in Hemodialysis Patients?Effects of vasopressinergic receptor agonists on sublingual microcirculation in norepinephrine-dependent septic shockCopeptin, Insulin Resistance, and Risk of Incident Diabetes in Older Men.Use of inotropes and vasopressor agents in critically ill patients.Role of vasopressin and terlipressin in refractory shock compared to conventional therapy in the neonatal and pediatric population: a systematic review, meta-analysis, and trial sequential analysisDiagnosis and treatment of severe sepsis.Selective V(1a) agonism attenuates vascular dysfunction and fluid accumulation in ovine severe sepsisSesamol ameliorates hypotension by modulating cytokines and PPAR-gamma in systemic inflammatory responseVascular KCNQ potassium channels as novel targets for the control of mesenteric artery constriction by vasopressin, based on studies in single cells, pressurized arteries, and in vivo measurements of mesenteric vascular resistance.Copeptin and the risk of incident stroke, CHD and cardiovascular mortality in older men with and without diabetes: The British Regional Heart Study.Pharmacological optimization of tissue perfusion.Increased copeptin levels in metabolic syndrome from a Romanian population.Terlipressin: a promising vasoactive agent in hemodynamic support of septic shock.Hormones and antioxidant systems: role of pituitary and pituitary-dependent axes.Arginine vasopressin for the treatment of septic shock in adults.Current management of sepsis in critically ill adult patients.Therapeutic applications of vasopressin in pediatric patients.Dialysis hypotension: a role for inadequate increase in arginine vasopressin levels? A systematic literature review and meta-analysis.Discontinuation of Vasopressin Before Norepinephrine in the Recovery Phase of Septic Shock.Osmolality and blood pressure stability during hemodialysis.VRQ397 (CRAVKY): a novel noncompetitive V2 receptor antagonist.Copeptin, a Marker of Vasopressin, Predicts Vascular Dementia but not Alzheimer's Disease.Hereditary nephrogenic diabetes insipidus: a major conundrum during labour and delivery.Vasopressin and copeptin levels in children with sepsis and septic shock.Pituitary-adrenal response to acute and repeated mild restraint, forced swim and change in environment stress in arginine vasopressin receptor 1b knockout mice.Systemic oxytocin and vasopressin excite gastrointestinal motility through oxytocin receptor in rabbits.Levels of vasopressin in children undergoing cardiopulmonary bypass.Vasopressin After the Fontan Operation.[Post-mortem organ donation].Treating Hypotension in Preterm Neonates With Vasoactive Medications.Definitions and pathophysiology of vasoplegic shock.
P2860
Q21195136-1D7B73C0-5E33-4A52-977F-69DDE34A00BDQ26773222-C4A6F73B-9376-4CD0-BFD0-8F49F5D99613Q26777564-6A014620-F9B6-4D91-8052-613CEB599263Q30952638-37701D79-4C53-44E4-A146-BC0CBEA0E69CQ33752658-A4F22591-8CAD-4797-A0EB-9E0D4783CE33Q33932812-6E0621F4-A1CB-4E4C-AF41-1DE83363AC06Q33972327-6C7C4709-A9CC-4137-A5E2-5576E4229075Q35137091-159205E1-41F2-4148-B443-F680C84F20A2Q35561294-4DA8CB36-BD50-426B-AC54-A5CC08B5AE6FQ35606726-DFDEE3B2-56D9-466E-9040-DE8D6D973030Q35908131-2D1B3F50-9549-4AE6-91D9-96548EF8EDC9Q36060397-CF7E48FB-DA62-4F1E-9A0D-443F52A448FBQ36147248-5BEB77F8-2799-4EEC-9966-6ACD35A5EEDDQ36241408-15E6AB20-B7F3-4573-9EB4-618BDFF69691Q36438852-CF492401-71DE-481F-A71C-9EAB1381619EQ36454207-32F5D263-F7B6-4A25-8683-86504CFADDEEQ36519265-8D56B81B-2A77-4DC2-9F5E-7F43E242A3A6Q37001792-3015B97E-12FC-41EA-91F5-8747C44F7828Q37143797-1679D7F6-A6EB-4665-99D0-4BA53E85E5BBQ37236713-6B1EB5D1-CE09-4569-8D88-978ABDA5BB9CQ37479457-B311F8A0-DFE8-4EF1-B01B-D945BE6771A4Q37593091-743EF9D9-EA06-409F-8F89-5262FD382D5BQ37772738-CB964C45-0E1B-4AAC-AE59-07DC09206DD0Q37793097-B15E65FF-48B5-4815-BE81-691CF6D10AE0Q37910252-28DDE557-F1EA-488B-9C41-F9A2C5BA4C47Q38008134-7C48C21E-E451-48DD-80A0-3DAA9EEBAEC0Q38185855-0FB05FD7-21DC-4FC0-8C09-3C59FD47539FQ38400500-70B57877-BDB1-45A5-9F1A-3736D5267AC2Q39425170-7BBA000F-E9AF-4C70-BBA8-723C963837B7Q39819177-B1CC29DF-1313-4105-BECE-C17EFA0BD5E2Q39850182-727533F6-9883-4ACB-BD96-7347791DA251Q40325224-E841C493-6699-4162-BD7C-586D7ADFB353Q43921824-B0E84223-3298-48C8-AA02-05D15F77AB71Q46684584-5DC3A9F7-E196-4CB8-B165-50C3B6A93253Q46990472-E4D2135D-D7F5-497F-99FB-0144CE2C3CF3Q48512010-76176822-E4ED-43A4-8D80-EFD3408A6381Q53232208-975CEF52-1A0F-41D2-9755-6001596FF22CQ53621075-1DF9C3A9-2CCE-4C1A-B869-F9255AA6BC87Q55133038-A1AD3E24-EE94-4490-A9EA-9F9B5CAD667FQ55510405-A0282FDB-5382-453C-8C7B-12ACCC6F1998
P2860
Vasopressin: mechanisms of action on the vasculature in health and in septic shock.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Vasopressin: mechanisms of action on the vasculature in health and in septic shock.
@ast
Vasopressin: mechanisms of action on the vasculature in health and in septic shock.
@en
type
label
Vasopressin: mechanisms of action on the vasculature in health and in septic shock.
@ast
Vasopressin: mechanisms of action on the vasculature in health and in septic shock.
@en
prefLabel
Vasopressin: mechanisms of action on the vasculature in health and in septic shock.
@ast
Vasopressin: mechanisms of action on the vasculature in health and in septic shock.
@en
P1476
Vasopressin: mechanisms of action on the vasculature in health and in septic shock.
@en
P2093
Lucinda K Barrett
P356
10.1097/01.CCM.0000251127.45385.CD
P407
P577
2007-01-01T00:00:00Z